Day: May 16, 2023

Unicycive Announces First Quarter 2023 Financial Results and Provides Business Update

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

Closed on previously announced transformational fundraising that included $30 million financing upfront with up to an additional $100 million tied to the satisfaction of milestones Continued progress with plan to file New Drug Application with the U.S. Food and Drug Administration in Q3 2023, with the potential for approval and launch in 2024 LOS ALTOS, Calif., May 16, 2023 (GLOBE NEWSWIRE) — Unicycive Therapeutics, Inc. (Nasdaq: UNCY) (the “Company” or “Unicycive”), a clinical-stage biotechnology company developing therapies for patients with kidney disease, today announced its financial results for the first quarter ended March 31, 2023 and provided a business update. “The first quarter of 2023 was transformational for Unicycive and positions us for continued success throughout the balance of the year and beyond as we expect...

REPEAT – Cleantech Power Corp. Enters Into Non-Binding Letter of Intent to Acquire Combined Heat and Power Assets

Written by Customer Service on May 16, 2023. Posted in Mergers And Acquisitions.

TORONTO, May 16, 2023 (GLOBE NEWSWIRE) — Cleantech Power Corp. (NEO: PWWR) (OTCQB: PWWRF) (Frankfurt: E43, WKN: A3EEHV) (“PWWR” or the “Company”), a diversified investment platform developing affordable, renewable, and reliable power and cleantech, is pleased to announce that the Company has entered into a non-binding letter of intent (the “Letter of Intent”) with an arm’s length third party to acquire, directly and indirectly, certain operating combined heat and power and other assets (the “CHP Assets”) located in North America (the “Potential Transaction”). Pursuant to the Letter of Intent, the Company may acquire the CHP Assets by making two payments. The first payment relates to CHP Assets which are past commercial operation and will consist of a payment of approx. $7.5 million (the “COD Payment”). The COD Payment will be made...

Avicanna Reports Q1 2023 Financial Statement

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

TORONTO, May 16, 2023 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products, is pleased announce the filing of interim financial statements for the three-month period ending March 31, 2023 (“Q1 2023”). Aras Azadian, CEO stated, “We are pleased to report on our continued progress related to our optimization of operations in addition to Canadian commercialization during the first quarter of 2023. We have achieved operational efficiencies that enables us to now focus on scaling our revenues which we expect to be growing during 2023 through our Canadian and international efforts.” Q1 2023 highlights:Shoppers Drug Mart partnership to transition Medical...

Salona Global Closes Acquisition of Arrowhead Medical, Provides Update on Biodex Integration; Posts First Quarter Results with Positive Adjusted EBITDA, 23% Annual Revenue Growth and 27% Growth in Annual Gross Profits, Improved Quarter-over-Quarter Gross Profit from 33.1% to 38%

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

SAN DIEGO, May 16, 2023 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (“Salona Global”, “SGMD” or the ‎‎“Company”) (TSXV:SGMD) today announced it closed its acquisition of Arrowhead Medical, LLC (“Arrowhead”), a recovery science medical device sales and distribution business expected to add $4.0 million in annual revenue to the Company, with an estimated 32% in gross profit. The Company also reported financial highlights for the first quarter of 2023, ending March 31, 2023, and provided details for its earnings call scheduled for 5pm EST today. Acquisition of Arrowhead and Biodex Integration Update The Company closed its acquisition of Arrowhead, a recovery science medical device sales and distribution business, on May 15, 2023. This addition to Salona Global is projected to add $4.0 million in revenue annually with...

Sigyn Therapeutics Reports First Quarter 2023 Financial Results

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

SAN DIEGO, CA, May 16, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announces financial results for the first quarter ended March 31, 2023. During the quarter, the Company continued its focus to initiate first-in-human clinical studies of Sigyn Therapy™ as a candidate to treat pathogen-associated inflammatory disorders. The therapeutic blood purification technology has been demonstrated to deplete a broad-spectrum of inflammatory cytokines, viral pathogens, and bacterial toxins from human blood plasma. First-in-human clinical studies are directed toward the enrollment of end-stage renal disease patients with endotoxemia and concurrent inflammation. Additionally, the Company recently introduced a development-stage...

Molekule Reports First Quarter 2023 Financial Results

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

Q1 2023 Revenues of $8.3 Million Exceed Guidance Announces Q2 2023 Revenue Guidance of Approximately $12 Million Up Approximately 45% with Substantially Improved EBITDA Due to Significant Increases in Gross Profit and Operating Leverage, All as Compared to Q1 2023 Remains on Target to Achieve Full Year Fiscal 2023 Revenue Guidance of Between $60-$70 Million PALM BEACH GARDENS, Fla., May 16, 2023 (GLOBE NEWSWIRE) — Molekule Group, Inc. (“Molekule” or the “Company”) (Nasdaq: MKUL), an emerging leader in air purification technology solutions, systems for healthcare and commercial smart building applications, and individual consumer protection, today reported financial results for the three months ended March 31, 2023 (“Q1 2023”). First Quarter 2023 Financial and Operational Highlights(Unless otherwise stated, comparisons are made...

Quipt Home Medical Reports Record Second Quarter Fiscal 2023 Financial Results Posting Revenue Growth of 73% and Adjusted EBITDA Growth of 86%

Written by Customer Service on May 16, 2023. Posted in Earnings Releases And Operating Results.

Posts Strong Adjusted EBITDA Margin of 22.5% and Sequential Organic Growth of 2.5% CINCINNATI, May 16, 2023 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company” or “Quipt“) (NASDAQ: QIPT; TSXV: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its second quarter fiscal 2023 financial results and operational highlights. These results pertain to the three and six months ended March 31, 2023, and are reported in U.S. Dollars. Quipt will host its Earnings Conference Call on Tuesday, May 16, 2023, at 10:00 a.m. (ET). The dial-in number is 1 (800) 319-4610 or 1 (604) 638-5340. The live audio webcast can be found on the investor section of the Company’s website through the following link: www.quipthomemedical.com. Financial Highlights:Revenues for fiscal Q2 2023...

Winshear Receives Authorisation to Initiate Activities at Its Gaban Gold Project in Puno, Peru

Written by Customer Service on May 16, 2023. Posted in Public Companies.

VANCOUVER, British Columbia, May 16, 2023 (GLOBE NEWSWIRE) — Winshear Gold Corp. (TSX-V: WINS), (“Winshear” or “the Company”) is pleased to report that it has received approval of its Authorization to Initiate Exploration Activities (“AIEA”) from the Ministry of Energy and Mines of Peru and is fully permitted to carry out a drilling program at its Gaban gold project in the Puno Orogenic Gold Belt of Peru. The environmental impact study or Declaración de Impacto Ambiental permit (DIA) for the project, previously received in October 2022, allows for the construction of up to 40 drill platforms in the Coritiri gold anomaly area. Gaban is being investigated as a possible hard rock source of the extensive alluvial goldfields being mined downstream at Madre de Dios which now cover over 1,900 square kilometers. Richard Williams, Winshear’s...

Liberty Networks Powers New Routes Across Florida with Infinera’s ICE6 800G Technology

Written by Customer Service on May 16, 2023. Posted in Public Companies.

SAN JOSE, Calif. and MIAMI, May 16, 2023 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) and Liberty Networks announced today the deployment of Infinera’s ICE6 800G coherent solution to upgrade and expand the capacity of Liberty Networks’ Florida Transport Network (FTN). This network enhancement enables Liberty Networks to offer new and efficient high-speed 400 GbE client services to its end-user customers. Leveraging Infinera’s ICE6 technology will also provide Liberty Networks with C+L-band capabilities, enabling Liberty Networks to increase its initial design capacity, offering an extremely scalable and robust network. A longtime Infinera customer, Liberty Networks owns and operates the largest state-of-the-art subsea multi-ring fiber optic network in Latin America and the Caribbean, with nearly 50,000 kilometers. Coupled with its...

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series

Written by Customer Service on May 16, 2023. Posted in Public Companies.

MINNEAPOLIS, May 16, 2023 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series on Monday, May 22, 2023. Inspire is scheduled to present at 2:00 p.m. Eastern Time. The presentation will be accessible via a live webcast here. A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com. About Inspire Medical SystemsInspire is a medical technology company focused on the development and commercialization...

Day: May 16, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals